Microsecond molecular dynamics studies of cholesterol-mediated myelin sheath degeneration in early Alzheimer's
Mayuri Gupta1, Donald F Weaver1,2
1Krembil Research Institute, University Health Network, 60 Leonard Avenue, Toronto, M5T 0S8, Canada. donald.weaver@uhnresearch.ca.
Abstract:
Cholesterol-mediated perturbations of membrane structural integrity are key early events in the molecular pathogenesis of Alzheimer's disease (AD). In AD, protein misfolding (proteopathy) and pro-inflammatory conditions (immunopathy) culminate in neuronal death, a process enabled by altered membrane biophysical properties which render neurons more susceptible to proteopathic and immunopathic cytotoxicities. Since cholesterol is a principal neuronal membrane lipid, normal cholesterol homeostasis is central to membrane health; also, since increased cholesterol composition is especially present in neuronal myelin sheath (i.e. brain "white matter"), recent studies have not surprisingly revealed that white matter atrophy precedes the conventional biomarkers of AD (amyloid plaques, tau tangles). Employing extensive microsecond all-atom molecular dynamics simulations, we investigated biophysical and mechanical properties of myelin sheath membrane as a function of cholesterol mole fraction (χCHL). Impaired χCHL modulates multiple bilayer properties, including surface area per lipid (APL), chain order, number and mass density profiles, area compressibility and bending moduli, bilayer thickness, lipid tilt angles, H-bonding interactions and tail interdigitation. The increased orientational ordering of both palmitoyl and oleoyl chains in model healthy myelin sheath (HMS) membranes illustrates the condensing effect of cholesterol. With an increase in χCHL, number density profiles of water tend to attain bulk water number density more quickly, indicating shrinkage in the interfacial region with increasing χCHL. The average tilt value is 11.5° for the C10-C13 angle in cholesterol and 64.2° for the P-N angle in POPC lipids in HMS. These calculations provide a molecular-level understanding of myelin sheath susceptibility to pathology as an early event in the pathogenesis of AD.
Insights
Altered cholesterol levels in brain white matter membranes disrupt structural integrity, contributing to early Alzheimer's disease (AD) pathogenesis. Molecular simulations reveal how cholesterol impacts myelin sheath properties, increasing neuronal vulnerability.
Area of Science:
- Neuroscience
- Biophysics
- Computational Biology
Background:
- Cholesterol's role in membrane integrity is crucial for neuronal health.
- Alzheimer's disease (AD) pathogenesis involves cholesterol-mediated membrane disruptions, proteopathy, and immunopathy.
- White matter atrophy, linked to cholesterol changes, precedes conventional AD biomarkers.
Purpose of the Study:
- To investigate the biophysical and mechanical properties of myelin sheath membranes.
- To understand how cholesterol mole fraction (χCHL) affects membrane structure and dynamics.
- To elucidate the molecular mechanisms underlying myelin sheath's susceptibility in early AD.
Main Methods:
- Utilized extensive microsecond all-atom molecular dynamics simulations.
- Analyzed various bilayer properties including APL, chain order, density profiles, moduli, thickness, tilt angles, H-bonding, and tail interdigitation.
- Modeled healthy myelin sheath (HMS) membranes with varying cholesterol concentrations.
Main Results:
- Increased cholesterol mole fraction (χCHL) alters multiple myelin sheath bilayer properties.
- Cholesterol exhibits a condensing effect, increasing orientational ordering of lipid chains.
- Higher χCHL leads to interfacial region shrinkage and altered water density profiles.
Conclusions:
- Impaired cholesterol homeostasis significantly affects myelin sheath biophysical properties.
- These alterations contribute to myelin sheath's susceptibility in the early stages of Alzheimer's disease.
- Provides a molecular-level understanding of AD pathogenesis linked to white matter changes.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment


